Pietrzko Magdalena Maria, Pietrzko Maciej, Niemczyk Wojciech, Skaba Dariusz, Wiench Rafał
Pietrzko Stomatology, Budowlanych 1 Street, 43-300 Bielsko-Biała, Poland.
Department of Periodontal Diseases and Oral Mucosa Diseases, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Pl. Traugutta 2, 41-800 Zabrze, Poland.
Biomedicines. 2025 Jan 13;13(1):182. doi: 10.3390/biomedicines13010182.
BACKGROUND/OBJECTIVES: The gold standard in the non-surgical treatment of periodontitis is scaling and root planning (SRP). In recent years, studies have emerged suggesting additional clinical benefits from the use of statins as an adjunct to classical periodontal disease treatment. The aim of the present study was to review the relevant literature relating to the subgingival use of statins as an adjunctive treatment to the classical, non-surgical treatment of periodontitis, with a particular focus on groups with general factors that may affect the outcome of treatment.
The authors conducted a systematic review following the PRISMA 2020 guidelines. The electronic literature search conducted included the MEDLINE (PubMed) database, Web of Science, Scopus, and Google Scholar from 1 January 2012 to 14 June 2024. The keywords used for the PubMed search were determined with the help of the MeSH Browser Tool and were as follows: Periodontitis [Mesh] AND Statin [Mesh] OR Simvastatin [Mesh] OR Atorvastatin [Mesh] or Rosuvastatin Calcium [Mesh]. Based on the authors' inclusion and exclusion criteria, 20 results were included in the review, out of 937.
The improvement was more pronounced in patients without systematic diseases compared to those with type II diabetes and in non-smokers compared to smoking patients. Greater improvements in clinical and radiological parameters were seen in patients diagnosed with aggressive periodontitis compared to patients with chronic periodontitis.
This literature review led the authors to the conclusion that statins applied locally might be competent agents for improving the therapeutic outcomes of SRP.
背景/目的:牙周炎非手术治疗的金标准是龈下刮治术和根面平整术(SRP)。近年来,有研究表明,他汀类药物作为经典牙周病治疗的辅助手段具有额外的临床益处。本研究的目的是回顾与他汀类药物龈下应用作为牙周炎经典非手术治疗辅助手段相关的文献,特别关注可能影响治疗结果的一般因素人群。
作者按照PRISMA 2020指南进行了系统评价。电子文献检索包括2012年1月1日至2024年6月14日的MEDLINE(PubMed)数据库、科学网、Scopus和谷歌学术。PubMed检索使用的关键词借助医学主题词浏览器工具确定,如下:牙周炎[医学主题词] AND 他汀类药物[医学主题词] OR 辛伐他汀[医学主题词] OR 阿托伐他汀[医学主题词] 或 瑞舒伐他汀钙[医学主题词]。根据作者的纳入和排除标准,937项结果中有20项被纳入综述。
与患有II型糖尿病的患者相比,无系统性疾病的患者改善更为明显;与吸烟患者相比,非吸烟患者改善更为明显。与慢性牙周炎患者相比,侵袭性牙周炎患者在临床和放射学参数方面有更大改善。
这篇文献综述使作者得出结论,局部应用他汀类药物可能是改善SRP治疗效果的有效药物。